Clinical Radiology
Volume 64, Issue 3 , Pages 238-249 , March 2009

Chronic left ventricular failure: the role of imaging in diagnosis and planning of conventional and novel therapies

Received 17 July 2008 ,Revised 26 September 2008 ,Accepted 14 October 2008.

References 

  1. Clegg AJ, Scott DA, Loveman E, et al. Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation. Heart J. 2006;27:2929–2938
  2. Donal E, Leclercq C, Linde C, et al. Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J. 2006;27:1018–1025
  3. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001;38:2101–2113
  4. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93:1137–1146
  5. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 1995;26:1565–1574
  6. Sutton MS, Keane MG. Reverse remodelling in heart failure with cardiac resynchronisation therapy. Heart. 2007;93:167–171
  7. Vitali E, Colombo T, Fratto P, et al. Surgical therapy in advanced heart failure. Am J Cardiol. 2003;8(91):88F–94F
  8. Mock MB, Ringqvist I, Fisher LD, et al. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS). Circulation. 1982;66:562–568
  9. Underwood SR, Bax JJ, vom Dahl J, et al. Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J. 2004;25:815–836
  10. Kasner M, Westermann D, Steendijk P, et al. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation. 2007;116:637–647
  11. Omoto R, Kyo S, Matsumura M, et al. Evaluation of biplane color Doppler transesophageal echocardiography in 200 consecutive patients. Circulation. 1992;85:1237–1247
  12. Gould KL. Quantitative imaging in nuclear cardiology. Circulation. 1982;66:1141–1146
  13. loannidis JPA, Trikalinos TA, Danias PG. Electrocardiogram-gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: a meta-analysis. J Am Coll Cardiol. 2002;39:2059–2068
  14. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374–379
  15. Assomull RG, Pennell DJ, Prasad SK. Cardiovascular magnetic resonance in the evaluation of heart failure. Heart. 2007;93:985–992
  16. O'Regan DP, Schmitz SA. Establishing a clinical cardiac MRI service. Clin Radiol. 2006;61:211–224
  17. Hartiala JJ, Mostbeck GH, Foster E, et al. Velocity encoded cine MRI in the evaluation of left ventricular diastolic function. Measurement of mitral valve and pulmonary vein flow velocities and flow volume across the mitral valve. Am Heart J. 1993;125:1054–1066
  18. Jackson E, Bellenger N, Seddon M, et al. Ischaemic and non-ischaemic cardiomyopathies—cardiac MRI appearances with delayed enhancement. Clin Radiol. 2007;62:395–403
  19. Mollet NR, Cademartiri F, Carlos AG, et al. High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation. 2005;112:2318–2323
  20. Leber AW, Knez A, Von Ziegler F, et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol. 2005;46:147–154
  21. Schroeder S, Achenbach S, Bengel F, et al. Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a writing group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. Eur Heart J. 2008;29:531–556
  22. Large S. Surgery for heart failure. Heart. 2007;93:392–402
  23. Califf RM, Harrell FE, Lee KL, et al. The evolution of medical and surgical therapy for coronary artery disease: a 15 year perspective. J Am Med Assoc. 1989;261:2077–2086
  24. Holmes DR, Davis KB, Mock MB, et al. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. Circulation. 1986;73:1254–1263
  25. Knuuti J, Bengel FM. Positron emission tomography and molecular imaging. Heart. 2008;94:360–367
  26. Kühl HP, Beek AM, van der Weerdt AP, et al. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with 18F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2003;41:1341–1348
  27. Maddahi J, Schelbert H, Brunken R, et al. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nuc Med. 1994;35:707–715
  28. Anon . Diagnostic procedures — adult patients. Administration of Radioactive Substances Advisory Committee (ARSAC); 2002;37–39
  29. Bonow RO, Dilsizian V. Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium. J Nucl Med. 1992;33:815–818
  30. Sawada SG, Allman KC, Muzik O, et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol. 1994;22:92–98
  31. Sciagra R, Pellegri M, Pupi A, et al. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 2000;36:739–745
  32. Cornel JH, Bax JJ, Elhendy A, et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularisation in patients with stable coronary artery disease. J Am Coll Cardiol. 1998;31:1002–1010
  33. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularisation in patients with ischaemic congestive heart failure. J Am Coll Cardiol. 1999;33:1848–1854
  34. Bax JJ, Poldermans D, Elhendy A, et al. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol. 2001;26:141–186
  35. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol. 1998;31:1040–1048
  36. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–1453
  37. Choi KM, Kim RJ, Gubernikoff G, et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104:1101–1107
  38. Selvanayagam JB, Kardos A, Francis JM, et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation. 2004;110:1535–1541
  39. Ryan R, Abbara S, Colen RR, et al. Cardiac valve disease: spectrum of findings on cardiac 64-MDCT. AJR Am J Roentgenol. 2008;190:W294–W303
  40. Lung B, Gohlke-Barwolf C, Tornos P, et al. Working Group on Valvular Heart Disease recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J. 2002;23:1252–1266
  41. Fischer JL, Haberer T, Dickson D, et al. Comparison of Doppler echocardiographic methods with heart catheterisation in assessing aortic valve area in 100 patients with aortic stenosis. Br Heart J. 1995;73:293–298
  42. Bernard Y, Meneveau N, Vuillemenot A, et al. Planimetry of aortic valve area using multiplane transoesophageal echocardiography is not a reliable method for assessing severity of aortic stenosis. Heart. 1997;78:68–73
  43. Malyar NM, Schlosser T, Barkhausen J, et al. Assessment of aortic valve area in aortic stenosis using cardiac magnetic resonance tomography: comparison with echocardiography. Cardiology. 2008;109:126–134
  44. Feuchtner GM, Muller S, Bonatti J, et al. Sixty-four slice CT evaluation of aortic stenosis using planimetry of the aortic valve area. AJR Am J Roentgenol. 2007;189:197–203
  45. Jassal DS, Shapiro MD, Neilan TG, et al. 64-slice multidetector computed tomography (MDCT) for detection of aortic regurgitation and quantification of severity. Invest Radiol. 2007;42:507–512
  46. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755–763
  47. Westaby S. Non-transplant surgery for heart failure. Heart. 2000;83:603–610
  48. Iung B. Management of ischaemic mitral regurgitation. Heart. 2003;89:459–464
  49. Westenberg JJM, Doornbos J, Versteegh MIM, et al. Accurate quantitation of regurgitant volume with MRI in patients selected for mitral valve repair. Eur J Cardiothorac Surg. 2005;27:462–466
  50. Alkadhi H, Wildermuth S, Bettex DA, et al. Mitral regurgitation: quantification with 16-detector row CT—initial experience. Radiology. 2006;238:454–463
  51. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007–2018
  52. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–1853
  53. Leclerq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol. 2002;39:194–201
  54. Bleeker GB, Yu CM, Nihoyannopoulos P, et al. Optimal use of echocardiography in cardiac resynchronisation therapy. Heart. 2007;93:1339–1350
  55. Ypenburg C, Schalij MJ, Bleeker GB, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J. 2007;28:33–41
  56. Muhlenbruch G, Koos R, Weldeberger J, et al. Imaging of the cardiac venous system: comparison of MDCT and conventional angiography. AJR Am J Roentgenol. 2005;185:1252–1257
  57. Sa MI, de Roos A, Westenberg JJ, et al. Imaging techniques in cardiac resynchronization therapy. Int J Cardiovasc Imaging. 2008;24:89–105
  58. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685–2694
  59. Wu JC, Bengel FM, Gambhir SS, et al. Cardiovascular molecular imaging. Radiology. 2007;244:337–355
  60. Arora R, Ferrick KJ, Nakata T, et al. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol. 2003;10:121–131
  61. Boehmer JP. Device therapy for heart failure. Am J Cardiol. 2003;91:53D–59D
  62. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435–1443
  63. Simon MA, Kormos RL, Murali S, et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation. 2005;112:32–36
  64. Stevenson LW, Rose EA. Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom?. Circulation. 2003;108:3059–3063
  65. Olivetti G, Abbi R, Quaina F, et al. Apoptosis in the failing human heart. N Engl J Med. 1997;336:1131–1141
  66. Hansen MW, Merchant N. MRI of hypertrophic cardiomyopathy: part 2. Differential diagnosis, risk stratification, and posttreatment MRI appearances. AJR Am J Roentgenol. 2007;189:1344–1352
  67. Trulock EP, Edwards LB, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: 22nd official adult lung and heart–lung transplant report—2005. J Heart Lung Transplant. 2005;24:956–967
  68. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: 24th Official Adult Heart Transplant Report—2007. J Heart Lung Transplant. 2007;26:769–781
  69. Sharples LD, Cafferty F, Demitis N, et al. Evaluation of the clinical effectiveness of the Ventricular Assist Device Program in the United Kingdom (EVAD UK). J Heart Lung Transplant. 2007;26:9–15
  70. Bogot NR, Durst R, Shaham D, et al. Cardiac CT of the transplanted heart: indications, technique, appearance, and complications. RadioGraphics. 2007;27:1297–1309
  71. Aranda JM, Hill J. Cardiac transplant vasculopathy. Chest. 2000;118:1792–1800
  72. Johnson DE, Alderman EL, Schroeder JS, et al. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol. 1991;17:449–457

PII: S0009-9260(08)00418-2

doi: 10.1016/j.crad.2008.10.009

Clinical Radiology
Volume 64, Issue 3 , Pages 238-249 , March 2009

Article Tools

* Image Usage & Resolution